Analgesics in South Korea

Despite the overall waning impact of the pandemic in South Korea, simultaneous new outbreaks of COVID-19, influenza, and the common cold (referred to as a “tripledemic” in the country) are leading to a sharp increase in the number of consumers requiring relief from their symptoms. Therefore, demand for both prescription medications and over-the-counter drugs from pharmacies has noticeably surged, leading to a further rise in value sales of analgesics in 2023.

The Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market
• Pinpoint growth sectors and identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop.